Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic analysis of tumor cell nuclear expulsion reveals significant cell adhesion and RNA binding programs in extracellular chromatin. | Sci Rep | 2025 | 40751052 | PubTator, text mining | PubMed |
| Bacterial two-hybrid systems evolved: innovations for protein-protein interaction research. | J Bacteriol | 2025 | 40748058 | PubTator, text mining | PubMed |
| The neuroprotective role of chlorogenic acid and Fisetin in differentiated neuronal cell line-SHSY5Y against amyloid-β-induced neurotoxicity. | Toxicol In Vitro | 2025 | 40695427 | PubTator, text mining | PubMed |
| Utilizing small molecules to probe and harness the proteome by pooled protein tagging with ligandable domains. | Front Pharmacol | 2025 | 40626313 | PubTator, text mining | PubMed |
| Author Correction: Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents. | Nat Commun | 2025 | 40610505 | PubTator, text mining | PubMed |
| Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways. | Int J Mol Sci | 2025 | 40565046 | PubTator, text mining | PubMed |
| A 3D generation framework using diffusion model and reinforcement learning to generate multi-target compounds with desired properties. | J Cheminform | 2025 | 40468393 | PubTator, text mining | PubMed |
| Broad Target Screening Reveals Abundance of FKBP12-Based Molecular Glues in Focused Libraries. | J Med Chem | 2025 | 40336336 | PubTator, text mining | PubMed |
| Cellular parameters shaping pathways of targeted protein degradation. | Commun Biol | 2025 | 40316744 | PubTator, text mining | PubMed |
| Anchor-Away: Efficient, Conditional Depletion of Nuclear Proteins in Saccharomyces cerevisiae. | Methods Mol Biol | 2025 | 40257568 | PubTator, text mining | PubMed |
| Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma. | Haematologica | 2025 | 40241574 | PubTator, text mining | PubMed |
| Study on drug-mediated protein-protein interaction in single living cells by fluorescence cross-correlation spectroscopy. | Analyst | 2025 | 40195613 | PubTator, text mining | PubMed |
| New strategies to enhance the efficiency and precision of drug discovery. | Front Pharmacol | 2025 | 40008135 | PubTator, text mining | PubMed |
| Discovery of fully synthetic FKBP12-mTOR molecular glues. | Chem Sci | 2025 | 39916884 | PubTator, text mining | PubMed |
| Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection. | Mol Ther | 2025 | 39799394 | PubTator, text mining | PubMed |
| Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi. | Proc Natl Acad Sci U S A | 2025 | 39739817 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Exploiting the DCAF16-SPIN4 interaction to identify DCAF16 ligands for PROTAC development. | RSC Med Chem | 2025 | 39691404 | PubTator, text mining | PubMed |
| Time-dependent effect of FKBP12 loss in the development of dilated cardiomyopathy. | J Gen Physiol | 2025 | 39665747 | PubTator, text mining | PubMed |
| Rendering Proteins Fluorescent Inconspicuously: Genetically Encoded 4-Cyanotryptophan Conserves Their Structure and Enables the Detection of Ligand Binding Sites. | Angew Chem Int Ed Engl | 2025 | 39632265 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=3